C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
1.960
-0.070 (-3.45%)
At close: Jan 29, 2026, 4:00 PM EST
1.960
0.00 (-0.03%)
After-hours: Jan 29, 2026, 4:29 PM EST
C4 Therapeutics Market Cap
C4 Therapeutics has a market cap or net worth of $189.47 million as of January 29, 2026. Its market cap has decreased by -23.31% in one year.
Market Cap
189.47M
Enterprise Value
58.44M
1-Year Change
-23.31%
Ranking
Category
Stock Price
$1.96
Market Cap Chart
Since the IPO on October 2, 2020, C4 Therapeutics's market cap has decreased from $772.72M to $189.47M, a decrease of -75.48%. That is a compound annual growth rate of -23.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 196.74M | 6.28% |
| Dec 31, 2025 | 185.11M | -27.16% |
| Dec 31, 2024 | 254.12M | -8.73% |
| Dec 29, 2023 | 278.44M | -3.60% |
| Dec 30, 2022 | 288.85M | -81.55% |
| Dec 31, 2021 | 1.57B | 9.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Camp4 Therapeutics | 207.52M |
| Century Therapeutics | 206.06M |
| Ovid Therapeutics | 201.79M |
| Editas Medicine | 201.09M |
| Galectin Therapeutics | 198.58M |
| Milestone Pharmaceuticals | 197.07M |
| Jyong Biotech | 194.56M |
| Humacyte | 193.00M |